Device Trial Radar · NCT00604799
VALOR: The Talent Thoracic Stent Graft System Clinical Study
Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
379
Actual
Start
Jul 2003
Primary completion
Jun 2006
Study completion Jun 2011
Sponsor
- Lead sponsor
- MedtronicPublic (MDT)
- Sponsor type
- Industry
- First posted
- Jan 30, 2008
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A Descending Thoracic Aneurysm is a bulge in the aorta. The aorta is a large blood vessel that carries blood away from your heart to organs in the rest of your body. Your aneurysm is caused by a weakening in the artery wall. If left untreated, this bulge may continue to grow larger and may ultimately rupture (break open) or extend in size to seriously affect other major arteries in the area. In this Research Study a device will be placed inside your aorta to block the weakened part of the artery wall from the circulatory system. Information will be collected on the performance for the device for 5 years.
Conditions
- Thoracic Aortic Aneurysms
Interventions
Talent Thoracic Stent GraftDevice
TEVAR
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Efficacy Endpoint: proportion of patients in the Test Group who have successful aneurysm treatment at the 12-month follow-up visit.Time frame: 12 months
1 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Pennsylvania Hospital
Philadelphia, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.